GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HLB Pharmaceutical Co Ltd (XKRX:047920) » Definitions » Total Assets

HLB Pharmaceutical Co (XKRX:047920) Total Assets : ₩160,075 Mil (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is HLB Pharmaceutical Co Total Assets?

HLB Pharmaceutical Co's Total Assets for the quarter that ended in Sep. 2024 was ₩160,075 Mil.

Warning Sign:

If a company builds assets at 41.5% a year, faster than its revenue growth rate of 21.8% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, HLB Pharmaceutical Co's average Total Assets Growth Rate was -4.70% per year. During the past 3 years, the average Total Assets Growth Rate was 50.60% per year. During the past 5 years, the average Total Assets Growth Rate was 41.50% per year.

During the past 10 years, HLB Pharmaceutical Co's highest 3-Year average Total Assets Growth Rate was 56.60%. The lowest was 2.20%. And the median was 17.90%.

Total Assets is connected with ROA %. HLB Pharmaceutical Co's annualized ROA % for the quarter that ended in Sep. 2024 was 2.39%. Total Assets is also linked to Revenue through Asset Turnover. HLB Pharmaceutical Co's Asset Turnover for the quarter that ended in Sep. 2024 was 0.22.


HLB Pharmaceutical Co Total Assets Historical Data

The historical data trend for HLB Pharmaceutical Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Pharmaceutical Co Total Assets Chart

HLB Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 45,845.87 111,419.82 127,632.31 142,177.11 141,351.63

HLB Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 133,051.97 141,351.63 170,633.39 157,459.35 160,074.80

HLB Pharmaceutical Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

HLB Pharmaceutical Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=88153.4+53198.232
=141,352

HLB Pharmaceutical Co's Total Assets for the quarter that ended in Sep. 2024 is calculated as

Total Assets=Total Equity (Q: Sep. 2024 )+Total Liabilities (Q: Sep. 2024 )
=119480.837+40593.965
=160,075

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HLB Pharmaceutical Co  (XKRX:047920) Total Assets Explanation

Total Assets is connected with ROA %.

HLB Pharmaceutical Co's annualized ROA % for the quarter that ended in Sep. 2024 is

ROA %=Net Income (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=3792.256/( (157459.35+160074.803)/ 2 )
=3792.256/158767.0765
=2.39 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

HLB Pharmaceutical Co's Asset Turnover for the quarter that ended in Sep. 2024 is

Asset Turnover
=Revenue (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=34767.222/( (157459.35+160074.803)/ 2 )
=34767.222/158767.0765
=0.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

HLB Pharmaceutical Co Total Assets Related Terms

Thank you for viewing the detailed overview of HLB Pharmaceutical Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


HLB Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
67, Euiui-ro, Songpa-gu, MK Tower 9th Floor, Seoul, KOR
HLB Pharmaceutical Co Ltd is a research-oriented pharmaceutical company. It is engaged in developing medicines and drugs. Its products include skeletal muscle relaxant, pain relief drugs, blood pressure-lowering agents, local anaesthetics, digestive system drugs, antacids, vitamins, haemorrhoid solvents, insect repellents, peptic ulcer solvents, and other products.

HLB Pharmaceutical Co Headlines

No Headlines